Breaking News Instant updates and real-time market news.

2019-10-18 06:36:53 GOLD Barrick Gold $17.10 0.15 (0.88%) 06:36 10/18/19 10/18 06:36 10/18/19 06:36	Barrick Gold upgraded to Outperform from Market Perform at Raymond James Raymond James analyst Brian Macarthur upgraded Barrick Gold to Outperform from Market Perform with a C$28.90 price target.	06 Nov
GOLD Barrick Gold $17.10 0.15 (0.88%) 09/12/19 MACQ 09/12/19 INITIATION MACQ Outperform Barrick Gold initiated with an Outperform at Macquarie Macquarie analyst Michael Siperco initiated Barrick Gold with an Outperform rating. 10/03/19 DBAB 10/03/19 UPGRADE Target $45 DBAB Buy Deutsche Bank upgrades Newmont Goldcorp to Buy after underperformance Deutsche Bank analyst Chris Terry upgraded Newmont Goldcorp (NEM) to Buy from Hold and raised his price target for the shares to $45 from $44. Shares of Newmont have significantly underperformed compared to its closest peer Barrick Gold (GOLD) and also versus the gold price, Terry tells investors in a research note. The analyst, who remains positive on gold, believes Newmont's headwinds are bottoming and that the stock is attractive at current levels. 10/03/19 NATB 10/03/19 INITIATION NATB Outperform Barrick Gold initiated with an Outperform at National Bank National Bank initiated Barrick Gold with an Outperform and $C31 price target. 10/10/19 ADAM 10/10/19 UPGRADE ADAM Buy Barrick Gold upgraded to Buy from Hold at Canaccord

2019-10-18 06:36:53

GOLD

Barrick Gold

$17.10: 0.15 (0.88%)

06:36

10/18/19

10/18

06:36

10/18/19

06:36

Barrick Gold upgraded to Outperform from Market Perform at Raymond James

Raymond James analyst Brian Macarthur upgraded Barrick Gold to Outperform from Market Perform with a C$28.90 price target.

06
Nov

GOLD Barrick Gold

$17.10: 0.15 (0.88%)

09/12/19: MACQ

10/03/19: DBAB

10/03/19: NATB

10/10/19: ADAM

TODAY'S FREE FLY STORIES

ZM Zoom Video $69.73 -0.22 (-0.31%) 07:33 12/06/19 12/06 07:33 12/06/19 07:33 Recommendations	Zoom Video analyst commentary » Zoom Video price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Dec
ONTX Onconova $0.30 -0.0148 (-4.77%) 07:32 12/06/19 12/06 07:32 12/06/19 07:32 Hot Stocks	Onconova, Inceptua announce Pre-approval Access collaboration for rigosertib » Onconova Therapeutics and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BHVN Biohaven Pharmaceutical $53.79 -0.235 (-0.44%) 07:32 12/06/19 12/06 07:32 12/06/19 07:32 Hot Stocks	Biohaven's troriluzole successfully advances past interim futility analysis » Biohaven announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SAGE Sage Therapeutics $60.11 -89.11 (-59.72%) 07:30 12/06/19 12/06 07:30 12/06/19 07:30 Recommendations	Sage Therapeutics analyst commentary » Sage Therapeutics price… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CRIS Curis $1.86 0.045 (2.48%) 07:29 12/06/19 12/06 07:29 12/06/19 07:29 Hot Stocks	Curis provides updated results from Phase 1 dose escalation study of CA-4948 » Curis announced updated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Dec

XNCR Xencor $40.63 0.05 (0.12%) 07:29 12/06/19 12/06 07:29 12/06/19 07:29 Conference/Events	Xencor to host analyst & investor meeting » Analyst & Investor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Dec 09 Dec
MRVL Marvell $23.44 -0.48 (-2.01%) 07:27 12/06/19 12/06 07:27 12/06/19 07:27 Recommendations	Marvell analyst commentary » Marvell price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec 06 Jan
SON Sonoco $59.91 -0.04 (-0.07%) 07:25 12/06/19 12/06 07:25 12/06/19 07:25 Conference/Events	Sonoco to host investor meeting » Investor meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Dec 09 Dec 13 Dec
RRC Range Resources $3.59 0.01 (0.28%) 07:23 12/06/19 12/06 07:23 12/06/19 07:23 Downgrade	Range Resources rating change » Range Resources… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MR Montage Resources $5.30 0.09 (1.73%) 07:22 12/06/19 12/06 07:22 12/06/19 07:22 Upgrade	Montage Resources rating change » Montage Resources… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec

TGTX TG Therapeutics $7.68 -0.51 (-6.23%) 07:19 12/06/19 12/06 07:19 12/06/19 07:19 Conference/Events	TG Therapeutics to host investor & analyst meeting » Investor & Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Dec 09 Dec
SAGE Sage Therapeutics $60.11 -89.11 (-59.72%) 07:15 12/06/19 12/06 07:15 12/06/19 07:15 Downgrade	Sage Therapeutics rating change » Sage Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AQST Aquestive Therapeutics $8.36 -0.42 (-4.78%) 07:15 12/06/19 12/06 07:15 12/06/19 07:15 Conference/Events	Aquestive Therapeutics to host investor & analyst meeting » Investor & Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec
OKTA Okta $119.18 -2.64 (-2.17%) 07:13 12/06/19 12/06 07:13 12/06/19 07:13 Recommendations	Okta analyst commentary » Okta price target raised… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Dec
PHG Philips 07:13 12/06/19 12/06 07:13 12/06/19 07:13 Upgrade	Philips rating change » Morgan Stanley upgrades… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

SAGE Sage Therapeutics $60.11 -89.11 (-59.72%) 07:10 12/06/19 12/06 07:10 12/06/19 07:10 Recommendations	Sage Therapeutics analyst commentary » Sage Therapeutics price… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CNST Constellation Pharmaceuticals $42.66 -3.34 (-7.26%) 07:08 12/06/19 12/06 07:08 12/06/19 07:08 Conference/Events	Constellation Pharmaceuticals to host investor meeting » Investor meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Dec 09 Dec
PBYI Puma Biotechnology $7.43 -1.52 (-16.98%) 07:07 12/06/19 12/06 07:07 12/06/19 07:07 Initiation	Puma Biotechnology initiated » Puma Biotechnology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MGM MGM Resorts $31.94 0.17 (0.54%) 07:06 12/06/19 12/06 07:06 12/06/19 07:06 Initiation	MGM Resorts initiated » MGM Resorts initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
OKTA Okta $119.18 -2.64 (-2.17%) 07:05 12/06/19 12/06 07:05 12/06/19 07:05 Recommendations	Okta analyst commentary » Okta traction in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Dec

RCKT Rocket Pharmaceuticals $19.76 0.54 (2.81%) 07:05 12/06/19 12/06 07:05 12/06/19 07:05 Hot Stocks	Rocket Pharmaceuticals announces first patient treated in Phase 2 RP-L102 study » Rocket Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Dec 08 Dec
UCBJY UCB $0.00 (0.00%) 07:05 12/06/19 12/06 07:05 12/06/19 07:05 Hot Stocks	UCB: Phase 3 BE SURE results met co-primary, ranked secondary endpoints » UCB announced positive… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SLG SL Green Realty $85.75 -0.08 (-0.09%) 07:05 12/06/19 12/06 07:05 12/06/19 07:05 Conference/Events	SL Green Realty to host investor meeting » Investor meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec
TELA Tela Bio $12.11 -1.09 (-8.26%) 07:04 12/06/19 12/06 07:04 12/06/19 07:04 Hot Stocks	Tela Bio awarded contract with HealthTrust Purchasing Group » TELA Bio announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ULTA Ulta Beauty $236.09 -3.27 (-1.37%) 07:03 12/06/19 12/06 07:03 12/06/19 07:03 Recommendations	Ulta Beauty analyst commentary » Ulta Beauty results… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Mar

Events

Earnings calls, analyst events, roadshows and more

HHR
Today at 08:00

HeadHunter - HHR Conference Calls
BIG
Today at 08:00

Big Lots - BIG Conference Calls
XIN
Today at 08:00

Xinyuan Real Estate - XIN Conference Calls
SON
Today at 08:00

Sonoco Products Co. Firm Sponsored Meetings

New York Palace Hotel, Villard Ballroom 455 Madison Avenue, New York, NY
Today at 08:30

Employment Situation: Non-Farm Payrolls M/M: November 2019 Government Event
Today at 08:30

Employment Situation: Average Workweek All Employees: November 2019 Government Event
Today at 08:30

Employment Situation: Unemployment Rate: November 2019 Government Event
Today at 08:30

Employment Situation: Manufacturing Payrolls M/M: November 2019 Government Event
Today at 08:30

Employment Situation: Participation Rate: November 2019 Government Event
Today at 08:30

Employment Situation: Average Hourly Earnings M/M: November 2019 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	ELF X ELF e.l.f. Beauty Block Trade Managers: Morgan Stanley Priced at: $15.90 3.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AER X AER AerCap Spot Secondary Managers: Citi Priced at: $60.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CWEN X CWEN Clearway Energy Spot Secondary Managers: RBC Capital Priced at: $18.70 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FSV X FSV FirstService Spot Secondary Managers: BMO Capital & TD Securities Priced at: $92.50 2.165M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ARWR X ARWR Arrowhead Secondary Managers: Goldman Sachs, Jefferies, Piper Jaffray & Cantor Fitzgerald, Baird, B. Riley FBR Priced at: $58.00 4M Shares ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: H.C. Wainwright Priced at: $2.50 5.125M Shares KOD X KOD Kodiak Sciences Secondary Managers: JPMorgan, Goldman Sachs & Jefferies Priced at: $46.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRAY X VRAY ViewRay Secondary Managers: Piper Jaffray Priced at: $3.13 41.55M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNNE X CNNE Cannae Holdings Spot Secondary Managers: BofA/Merrill & Stephens Priced at: $33.00 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLMD X RLMD Relmada Therapeutics Spot Secondary Managers: Jefferies, SVB Leerink & Guggenheim Priced at: $30.00 3.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RVNC X RVNC Revance Spot Secondary Managers: Cowen, Piper Jaffray & Stifel Priced at: $17.00 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	LMPX X LMPX LMP Automotive IPO Managers: ThinkEquity Priced at: $5.00 2.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CCC X CCC Clarivate Analytics Secondary Managers: Citi & Goldman Sachs Priced at: $17.25 43.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMMU X IMMU Immunomedics Secondary Managers: Goldman Sachs, BofA/Merrill, Cowen & Jefferies Priced at: $17.50 14.29M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUFN X TUFN Tufin Secondary Managers: JPMorgan, Barclays & Jefferies, Oppenheimer, Baird, Piper Jaffray, Stifel, William Blair Priced at: $17.00 4.28M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARDX X ARDX Ardelyx Spot Secondary Managers: Citi, Cowen, SVB Leerink & Piper Jaffray Priced at: $6.25 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MLND X MLND Millendo Therapeutics Spot Secondary Managers: Citi & SVB Leerink Priced at: $6.00 4.167M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NJR X NJR New Jersey Resources Spot Secondary Managers: Wells Fargo & JPMorgan, BBNT, TD Securities, Goldman Sachs, Janney Montgomery Scott, Siebert Williams Priced at: $41.25 5.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OMER X OMER Omeros Spot Secondary Managers: Cantor Fitzgerald Priced at: $13.10 3.816M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RC X RC Ready Capital Spot Secondary Managers: Morgan Stanley, UBS, Wells Fargo & Keefe Bruyette Priced at: $15.58 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial WHF X WHF WhiteHorse Finance Spot Secondary Managers: Raymond James, Keefe Bruyette & Deutsche Bank, Ladenburg, Oppenheimer, B. Riley FBR, National Securities Priced at: $13.83 2.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	DT X DT Dynatrace Secondary Managers: Goldman Sachs, JPMorgan, Citi, RBC Capital, BofA/Merrill, Barclays, UBS & Jefferies, Canaccord, WBLR BTIG, JMP Securities, KeyBanc, Raymond James, Academy Securities Priced at: $24.75 27.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVRI X EVRI Everi Holdings Secondary Managers: Jefferies, Stifel, Craig-Hallum & Raymond James, SunTrust Priced at: $11.25 10M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GDS X GDS GDS Holdings Secondary Managers: JPMorgan, RBC Capital & BofA/Merrill, Haitong International Priced at: $45.50 5.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLUG X PLUG Plug Power Secondary Managers: Morgan Stanley & Barclays Priced at: $2.75 40M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $13.25 11.18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVOP X EVOP EVO Payments Spot Secondary Managers: JPMorgan & Barclays Priced at: $27.60 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	TTEC X TTEC TTEC Holdings Secondary Managers: BofA/Merrill, Morgan Stanley, Cowen, Craig-Hallum & William Blair, Northland, HSBC $44.71 3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CATC X CATC Cambridge Bancorp Spot Secondary Managers: Keefe Bruyette $73.00-74.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ISEE X ISEE IVERIC bio Spot Secondary Managers: Cowen $4.30 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Barrick Gold upgraded to Outperform from Market Perform at Raymond James

TODAY'S FREE FLY STORIES

Get Full Fly Access